Persistent infection by hepatitis B virus (HBV
Introduction
Hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) is a major cause of death worldwide (Beasley & Hwang, 1984) . This type of HCC often contains integrated fragments of HBV DNA which, in certain examples, disturb growth-controlling genes by insertional mutagenesis or (in the case of related animal hepatitis viruses) by cis effects on their transcription (for review see Hildt et al., 1996 ; Robinson, 1994 ; Rogler & Chisari, 1992 ). An oncogenic HBV gene product has not yet been identified unequivocally. The transcription activating protein HBx of hepatitis B virus (for review see Henkler & Koshy, 1996) has for some time been thought to be responsible for the oncogenic potential of HBV (Zahm et al., 1988) . At least three mouse lines transgenic for HBx do not that of cell lines transformed with the complete genome, and latency of tumour induction in nude mice was significantly longer after inoculation of HBx than of HBV transformed FMH202 cell lines. A marker of complete transformation, p53, was found to be phosphorylated more strongly in HBx transfected cell lines than in controls, and a cellular kinase was found to be associated with p53 complexes from HBx transformed cell lines. p53 was of wild-type conformation and was located in the nucleus of transformed cells.
develop tumours (Balsano et al., 1994 ; Lee et al., 1990 ; Perfumo et al., 1992) . Only one mouse strain that spontaneously develops liver carcinoma has been reported to show a significantly increased occurrence of liver tumours when transgenic for HBx (Kim et al., 1991) .
The molecular mechanisms underlying the putative oncogenicity of human HBV are difficult to study in vitro because primary hepatocytes do not grow in culture. A further complication is that they cannot be transformed in a single step by activated cellular oncogenes such as the mutated c-Hras gene (Ho$ hne et al., 1993) . Immortalized, non-transformed human hepatocyte cultures are not available. To circumvent these obstacles, an immortalized foetal mouse hepatocyte line from the transgenic mouse strain FMH202 was used (Paul et al., 1988) . FMH202 cells contain the promoterless large tumour gene of simian virus 40 (SV40 TAg) as transgene, which they express at moderate levels. In contrast to malignant cells they do not grow either in soft agar or in nude mice, and their growth can be arrested at subconfluent levels by withdrawal of growth factors (Paul et al., 1988) . It has previously been demonstrated that this cell line can be very efficiently transformed to malignant growth by transfection with the viral genome (Ho$ hne et al., 1990) .
In this study the FMH202 cell line was co-transfected with expression vectors for the HBx protein and for the selectable marker neomycin resistance. After selection of neomycin resistant clones, several clonal cell lines were established that showed all features of transformation by HBx. In searching for a target molecule of the HBx protein, studies were also carried out on the tumour suppressor protein p53. This protein prevents gene rearrangements, amplifications and chromosome translocations by DNA damage-dependent cell cycle arrest in G1. Inactivation of p53 can be caused by certain mutations or by association with proteins of DNA tumour viruses (Hinds & Weinberg, 1994 ). An in vitro association of p53 and HBx has recently been reported (Feitelson et al., 1993 ; Truant et al., 1995 ; Wang et al., 1994) which would lead to a disturbance of wild-type p53 related functions (Wang et al., 1994 (Wang et al., , 1995 . Therefore aspects of p53 functions in the parental and HBx transformed FMH202 cell lines were studied.
Methods
Antibodies and vectors. PAb421, PAb246 and PAb240 against p53 and MAb p420 against SV40 TAg were purchased from Dianova. MAbs PAb242, PAb248 and 200.47 specific for p53 (described by Lane et al., 1996) were a generous gift of D. Lane (Dundee, UK). MAbs raised against HBx specific peptides ( Klein et al., 1991) were kindly provided by R. Klein and C. H. Schro$ der (DKFZ, Heidelberg, Germany) .
For eukaryotic HBx expression, a 944 bp EcoRV-BglII fragment (nt 1040-1984) from a complete HBV genome (HVHEPB1, genotype A, EMBL accession number X51970) was cloned into the BamHI site of the vector pKSV10 (Pharmacia) after filling up the sticky ends of the insert and of the vector with Klenow polymerase (plasmid pKSVx).
By site-directed mutagenesis (Kunkel, 1985) G at position 1443 was changed to T in the vector pKSVx1443 − . By this mutagenesis, GAA encoding Glu in the ORF of the HBx protein at amino acid 24 was changed to the stop codon TAA. The vectors were controlled by sequencing. The neomycin expression vector pKSVneo was described by Seifer et al. (1990 b) .
Southern blot, Northern blot and ribonuclease protection assay. DNA and RNA were purified from cells as previously described (Ho$ hne et al., 1987) by using a modification of the guanidinium isothiocyanate procedure. DNA samples were digested with EcoRI and HindIII (New England Biolabs) and analysed by electrophoresis in agarose gels. After blotting, filters were hybridized with [$#P]dCTPlabelled DNA probes. For Northern blots, RNA was electrophoresed in denaturing glyoxal agrose gels as described (Ho$ hne et al., 1987) .
For the ribonuclease protection assay (RPA), 10 µg of total cellular RNA was mixed with 5i10& c.p.m. labelled RNA probe. As probe, an HBV fragment spanning nt 247-2600 inserted via XbaI and ApaI into pBluescript II KS(j) was transcribed with T3 RNA polymerase using a kit from Stratagene (Fig. 1 A) . The ribonuclease assay was performed with an RPA kit from Ambion according to the manufacturer's instructions. The protected fragments were separated on a denaturing (8 M urea) polyacrylamide sequencing gel.
Immune blot. For immune blotting, cells from a 35 mm diameter dish were lysed on ice using RIPA buffer (10 mM Tris-HCl pH 8n1, 1 mM EDTA, 0n15 M NaCl, 1 % NP40, 1 % sodium desoxycholate, 1 mM PMSF) containing 30 µg\ml aprotinin, 50 µM leupeptin and 50 u\ml Benzon nuclease (Merck) to digest chromosomal DNA. The protein concentration was determined using the BCA assay (Pierce). Equal amounts of protein were loaded on the polyacrylamide gel.
Cells, cell culture and oncogenicity assays. FMH202 cells (Paul et al., 1988) were maintained in MX82 and MX83 medium (Hoffmann et al., 1989) as described (Ho$ hne et al., 1990) . Transfection by calcium phosphate precipitation (Gorman, 1985) was done with 10 µg pKSVx or pKSVx1443 − , respectively, and 1 µg pKSVneo and 8i10& FMH202 cells. FMHneo control clones received 10 µg pKSV10 and 1 µg pKSVneo. Neomycin resistant clones were selected with 200 µg of the neomycin analogue G418\ml.
As positive control, LTK4\36 or FMH119\6 was used. LTK4\36 is a murine fibroblast line transfected with a dimeric HBV genome which secretes HBV particles (Seifer et al., 1990 a, b) . FMH119\6 is a clone derived from FMH202 by transfection of a dimeric HBV genome (Ho$ hne et al., 1990) . FMH119\6 expresses all HBV products needed for particle formation, grows in soft agar and induces tumours in nude mice (Ho$ hne et al., 1990) . As negative control, the non-transfected murine fibroblast line LTK (Seifer et al., 1990 a, b) was used.
For soft agar assays, 250 cells were suspended in 0n3 % soft agar. Colonies 0n2 mm were counted after 14 days.
For nude mouse assays, 10( cells in 100 µl PBS were injected into the backs of 4-week-old NMRI nu\nu mice.
Radioimmune precipitation. Cells were metabolically labelled for 2 h with 150 µCi [$&S]methionine per 6 cm cell culture plate in 4 ml methionine-free medium. Cells were harvested by lysis in RIPA buffer. Equal amounts of trichloroacetic acid-precipitable $&S (1i10( c.p.m.) were immune precipitated with the MAbs as recommended by the manufacturer. Immune precipitates were collected and washed after binding to anti-mouse IgG agarose Bio-Beads (Bio-Rad) three times in RIPA buffer. After boiling the beads in Laemmli buffer, equal aliquots of the supernatant were applied to 12 % polyacrylamide gels. Gels were incubated in Amplify solution (Amersham) before drying and autoradiography.
For phosphorylation studies, cells were kept for 1 h in phosphate-free MX82 medium, washed and incubated on 10 cm diameter plates for 2 h with 300 µCi orthophosphate\ml medium. The cells were harvested and processed as above.
Cell fractionation. The following fractionation method gives a cytoplasmic and nuclear extract (Schmieg & Simmons, 1984) . The cells were first washed with PBS followed by a wash with a buffer containing 10 mM HEPES pH 6n6, 10 % glycerol, 5 mM MgCl # , 3 mM CaCl # , 1 mM DTT. Cells were lysed in situ with the same buffer containing 1 % NP40 for 15 min on ice (cytoplasmic extract). The remaining nuclei attached to the substrate were extracted with nuclei lysis buffer (20 mM Tris-HCl pH 9n0, 150 mM NaCl, 1 % NP40, 20 mM EDTA, 30 µg\ml aprotinin and 50 µM leupeptin) for 30 min on ice (nuclear extract).
In vitro protein kinase reaction. Immune complexes (PAb246) were washed three times with RIPA buffer, once with kinase buffer (see below) and then incubated in kinase buffer in the presence of [γ-$#P]ATP. The kinase reaction was carried out in buffer containing 50 mM Tris-HCl pH 7n5, 100 mM NaCl, 10 mM MnCl # , 1 mM DTT, 0n1 % Aprotinin at 30 mC for 30 min in a volume of 50 µl. The reaction was stopped by adding 10 vols of RIPA buffer containing 10 mM EDTA.
Immunofluorescence. Cells grown to confluence on cover slips in serum-free MX83 medium supplemented with hydrocortisone (100 ng\ml) and insulin (10 µg\ml) were shifted to growth arrest conditions in MX82 medium without insulin and hydrocortisone (Paul et al., 1988) . After 48 h cells were fixed in methanol-acetone at k20 mC for IP: 54.70.40.11
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Transformation by hepatitis B virus X protein Transformation by hepatitis B virus X protein 3 min. Blocking buffer consisted of 0n8 %BSA, 0n1 % cold fish gelatine, 5 % goat serum in PBS. Incubation of primary and secondary affinity-purified, fluorescein-coupled anti-mouse IgG F(abh) # fragment (Dianova) was done in 0n8 % BSA, 0n1 % cold fish gelatine, 1 % goat serum in 1i PBS. The washing buffer was 0n8 % BSA, 0n1 % cold fish gelatine in 1i PBS. Immunofluorescence was observed with a Nikon FXA fluorescence microscope.
Results

Expression of HBx in stably transfected FMH202 cells
For expression of sufficiently high levels of HBx protein, a vector (pKSVx) was constructed which contained the SV40 enhancer and early promoter and an HBV DNA fragment that spanned HBV enhancer I, the X promoter, the X gene and the HBV polyadenylation site (Fig. 1 A) . In order to ensure that the observed activities in transfected clones were due to HBx protein and not to HBV-derived nucleic acids, a control vector pKSVx1443 − was constructed which contained a stop codon instead of codon 24 of the X gene. Co-transfection of 8i10' cells with the HBx expression vector and the selection vector pKSVneo yielded 42 stable clones obtained after neomycin selection, 24 of which contained HBx DNA sequences as detected by filter hybridization. Seventeen of these 24 clones expressed HBx mRNA at levels detectable by filter hybridization. Transfection of 8n4i10' FMH202 cells with vector pKSVx1443 − yielded 88 neomycin resistant clones. Twenty-two of 47 clones expressed amounts of mutated HBx RNA that were detectable by filter hybridization (data not shown).
HBx RNA expression of six pKSVx1443 − transfected and two pKSVx transfected clones was controlled by performing RPA with total cellular RNA (Fig. 1 B) . All clones examined expressed HBx specific RNAs at different levels. Two major start sites, approximately 610 and 585 bp upstream of the viral poly(A) site, were detected in wild-type and mutant HBx transfected clones, i.e. around positions 1326 and 1351. In mutant X transfected clones at least one additional protected RNA with a length of around 541 bp, apparently starting around position 1443, was detected by RPA. This additional band can be explained by cleavage of the G\U mismatch at codon 1443 which was changed by site directed mutagenesis because the cellular (mutant HBx) RNA was hybridized with a HBx wild-type probe. A G\U mismatch is only cleaved with an efficiency of 60-70 % by the RNase mix used in the RPA (Myers et al., 1985) , which explains why full-length HBx mRNAs of 610 and 585 bp could be observed.
Using immune precipitation of $&S-labelled cell lysates or Western blot of unlabelled cell lysates, no protein clearly attributable to HBx protein was detected, even in the HBx clones expressing the highest amounts of HBx mRNA, when anti-HBx MAbs raised against five different HBx peptides were used as reagents (Klein et al., 1991 ; data not shown) . This is a problem also encountered by other groups (for example Doria et al., 1995 ; Luber et al., 1996) , and is probably due to the 
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low number of HBx molecules per cell and the short half-life of HBx (Schek et al., 1991) .
Growth of HBx-expressing clones in soft agar
For assay of tumorigenicity three clones expressing low (FMHx1), medium (FMHx5) and high (FMHx26) amounts of HBx mRNA were further characterized. As a negative control, 12 clonal cell lines (XM) transfected with pKSVx1443 − that expressed medium to high amounts of mutated X mRNA, and six clones derived from the transfection with empty expression vector pKSV10 mixed with selection vector pKSVneo (10 : 1, w\w), were taken. As a positive control, in vitro HBV transformed clone FMH119 containing several copies of dimerized HBV DNA (described by Ho$ hne et al., 1990) was used.
The cell lines expressing HBx mRNA formed colonies in soft agar with an efficiency of 6-9 % (Table 1) . The FMH119 cells grew with 67 % efficiency, showing much better growth in soft agar than the HBx transfected cell lines. All cell lines derived after transfection with pKSVx1443 − or pKSVneo showed no significant growth in soft agar ( 1 %).
Nude mouse tumours
Because growth in soft agar does not always correlate with malignant properties of cell lines (Shin et al., 1975) , the tumorigenicity of the three FMHx clones that grew in soft agar was studied by injection into groups of three to five nude mice. One clone transfected only with pKSV10\pKSVneo, as a negative control, and clone FMH119, as a positive control, were injected into nude mice. Only FMH119 and the two FMH clones expressing high and medium amounts of HBx mRNA formed tumours in nude mice after a long latency period. Clone FMHx1, which expressed lower amounts of HBx mRNA, failed to induce tumours in nude mice within 6 months (Table 1) . There was a minimum period of 50 days, up to a maximum of 100 days, between injection of the HBx expressing cell lines and the appearance of the first tumours. With the cell lines transformed by the complete HBV genome, all nude mice had developed tumours up to 1 cm in diameter within 50 days (Ho$ hne et al., 1990) .
SV40 large tumour antigen expression
To rule out the possibility that transformation of FMHx clones was due to activation of the promoter of the transgene SV40 TAg by the promiscuous transactivation properties of HBx, the expression of SV40 TAg RNA and protein was controlled. There was no difference between HBx, mutant HBx or neo-transfected stable FMH clones in the expression of SV40 TAg RNA and protein. Even in nude mouse tumours there was no upregulation of SV40 TAg mRNA expression ; instead, it even appeared as though the nude mouse tumours contained less SV40 TAg RNA (Fig. 2) .
Rearrangement of the integrated HBV DNA
Rearrangement of genomic DNA is a common event during multi-step carcinogenesis. Studies were carried out to investigate whether the integrated HBV sequences of the HBxexpressing FMH clones were stable after passage through nude mice. Southern blotting shows that HBV sequences were multiply integrated in the genome of the clones FMHx5 (Fig.  3) and FMHx26 (not shown). The pattern of integrated HBV DNA fragments was altered significantly in tumours that were derived from these clones in nude mice (compare lanes 2 and 4 in Fig. 3 ).
Expression of p53 in HBx transformed clones
To study the expression of p53 protein, the clonal cell lines were labelled for 2 h in vivo with [$&S]methionine. After lysis of the cells with RIPA buffer, p53 was immune precipitated with Table 1 ). The DNA was digested with EcoRI (E) and HindIII (H). The blotted genomic DNA was hybridized with an HBx specific probe.
PAb421 (not conformation-dependent) and PAb240 (mutant conformation-specific). 
Phosphorylation of p53
Because an increase of p53 phosphorylation has been reported after transformation of rat fibroblasts by SV40 TAg (Mu$ ller et al., 1993) , pKSVx and pKSVx1443 − transfected cell lines were labelled for 2 h in vivo with [$#P]orthophosphate. Fig. 4 (B) (lanes 3 and 4) shows that p53 is more strongly phosphorylated after transformation with HBx. The coprecipitated SV40 TAg was, however, not more strongly phosphorylated than in the controls. XM transfected control clones (lanes 5 and 6) also contained a p53 that was not more strongly phosphorylated than in the parental non-tumorigenic cell line FMH202 (data not shown). Again, no immune precipitation of p53 was observed when PAb240 was used (lanes 7-10), which recognizes the mutant conformation of p53 only.
Co-precipitation of cellular kinases by p53
In addition to increased phosphorylation of p53 after complete transformation by SV40 TAg, co-precipitation of cellular kinases (mainly casein kinase II) with p53 has been reported (Mu$ ller et al., 1993) . Studies were therefore carried out to determine whether increased phosphorylation of p53 in HBx transformed FMH202 cells went along with co-precipitation of cellular kinases by p53. p53 immune precipitated S. Schaefer and others S. Schaefer and others , 8) , and two non-transformed clones, XM1 (lanes 2, 5, 9) and XM6 (lanes 6, 10) were immunoprecipitated with the antibodies indicated and the immune complexes were analysed by SDS-gel electrophoresis and autoradiography. Lanes 1 and 2 (Contr.), no antibodies ; lanes 3-6, PAb421 directed against wt/mut p53 ; lanes 7-10, PAb240 recognizing the mutant conformation of p53.
with PAb246 was used in an in vitro kinase reaction under conditions that were described as optimal for p53 coprecipitated cellular kinases (Mu$ ller et al., 1993) . In vitro phosphorylation by cellular kinases in HBx transformed cell line HBx5 was found to be stronger than in control transfected cell line XM1 (Fig. 5) . The $#P signal from in vitro phosphorylated non-p53 proteins, mainly in the high molecular mass range around 80-100 kDa, showed that similar amounts of immune precipitates per lane had been loaded. The in vitro protein kinase reaction could be blocked completely by adding cold GTP (50 mM) (Fig. 5, lanes 2 and 4) which suggests that the co-precipitated cellular kinase was casein kinase II.
Intracellular distribution of p53
The intracellular localization of p53 is important for its regular function. Because cytoplasmic retention of p53 was reported for hepatic tumours that developed in mice transgenic for HBx (Ueda et al., 1995) and in transiently transfected HepG2 cells (Takada et al., 1997) , the intracellular distribution of p53 in our cell lines was investigated. Using p53 specific PAb421 for immune fluorescence, staining was found predominantly in the nucleus of growing cultures of FMHx and FMHxM clones (Fig. 6 A, top) . In contrast, in the transformed FMH clones X5 and X26 held under growth arrest conditions, staining was mainly cytoplasmic by immune fluorescence (Fig.  6 A, PAb421) and no p53 could be detected in the majority of the nuclei, whereas p53 was localized exclusively in the nucleus in the non-transformed pKSV1443 − expressing clone (XM1). The cytoplasmic staining was confirmed with PAb240 and PAb246 in clone FMHx5 (data not shown). But when using p53 specific antibodies PAb248 (Fig. 6 A) , PAb242 and 200.47 (data not shown), p53 was found exclusively in the nucleus. SV40 TAg was always found in the nucleus by immune fluorescence (Fig. 6 B) . With a mixture of five MAbs against HBx (Klein et al., 1991) , HBx could be detected in the cytoplasm.
To determine if the cytoplasmic staining for p53 in the transformed FMHx clones was due to unspecific staining by MAb PAb421, PAb240 and PAb246, p53 was immune precipitated from nuclear or cytoplasmic extracts of in vivo labelled cells (Fig. 7) . Much more p53 could be precipitated by PAb421 from nuclear extracts of HBx transformed clone FMHx5 held under growth arrest than from cytoplasmic extracts. There was no difference in the overall amount of p53 in the transformed clone X5 compared to the control XM1.
Discussion
The present study shows that expression of the HBV X protein alone is sufficient to transform an immortalized hepatocyte line to malignant growth in vitro. The transformation of FMH202 cells by HBx is not thought to be due to activation of transgene SV40 TAg expression, because the amount of TAg RNA and protein was not enhanced. The transforming effect of HBx in FMH202 cells was not very strong. Growth in soft agar was comparatively low, with an efficiency of only 6-9 % compared with the growth efficiencies of HBV transformed clones (Ho$ hne et al., 1990 ; Table 1 ). Also noteworthy are the very long latency of tumour induction in nude mice of HBx transfected clones, and the fact that clone X1 failed to induce tumours in nude mice (Table 1) Transformation by hepatitis B virus X protein Transformation by hepatitis B virus X protein Fig. 5 . In vitro phosphorylation of p53 by a co-precipitated kinase. p53 was immune precipitated with PAb246 from HBx transformed clone X5 (lanes 1 and 2) and control clone XM1 (lanes 3 and 4). Lanes 5 and 6 show control immune precipitations from clone XM1 done with no p53 specific antibody. In lanes 2, 4 and 6 cold GTP was added to a final concentration of 50 mM. Oguey et al. (1996) investigated the tumorigenic effect of HBx on a differentiated murine hepatocyte line, immortalized by TGF-α. These investigators also observed only a weak transforming effect of HBx. Only one of four HBx expressing clones tested induced tumours in nude mice (Oguey et al., 1996) .
Expression of HBx could be detected only on the RNA level. The start of the HBx message was determined by RPA. The position of the two start sites used in FMH202 cells correlates well with the use of start sites in the human liver cell line HepG2 (positions 1310p5, 1332p5 and 1340p5; Treinin & Laub, 1987) . Interestingly, in cell lines transfected with a replication competent dimer of HBV-DNA (FMH119\6 and LTK4\36 ; Fig. 1 B lanes 10 and 11, respectively) (Ho$ hne et al., 1990 ; Seifer et al., 1990 b) , the start site at position 1351 was used preferentially. M. Levrero and colleagues (personal communication) and Oguey et al. (1996) have reported difficulty in obtaining cell lines stably transfected with HBx. Two recent publications reported that HBx induces apoptosis (Chirillo et al., 1997 ; Su & Schneider, 1997) . Similar numbers of viable clones were obtained with and without functional HBx. The induction of apoptosis by HBx may depend on p53, which may be inactivated by SV40 TAg in this system.
The strikingly higher oncogenicity of HBV expressing FMH clones (Table 1 ; Ho$ hne et al., 1990) was not due to a much higher expression of HBx mRNA ( Fig. 1 ; data not shown). This observation suggests that HBV DNA may encode an unidentified second oncogenic factor which acts either independently or in co-operation with HBx protein (Hildt et al., 1996 ; Schaefer & Gerlich, 1995) . In this system, SV40 TAg and HBx probably act as complementing oncogenes in the complete transformation of the FMH202 cells, as does TGF-α in the system of Oguey et al. (1996) . However, it appears that HBx can also interact with other unidentified oncogenic factors, because immortalized mouse fibroblast lines which do not contain SV40 TAg also showed enhanced growth in soft agar after transfection with HBx (Seifer & Gerlich, 1992 ; Shirakata et al., 1989) .
The observed enhanced phosphorylation of p53 and coprecipitation of cellular kinases after transformation by HBx are interpreted as sequelae of complete transformation, similar to the results described by Mu$ ller et al. (1993) and Scheidtmann (1989) after complete transformation of rat cells by SV40 TAg. Fig. 4 (B) shows that p53 is more strongly phosphorylated in the HBx transformed cell line X5 than in control cell line XM1, which supports the observation of increased malignant potential of HBx transformed FMH202 cells. Furthermore, the in vitro kinase activity of immune precipitated p53 indicated that in the HBx transformed cell line X5 one or more cellular kinases were co-precipitated by p53 to a larger extent than in the control clone XM1. Mu$ ller et al. (1993) demonstrated that casein kinase II was the major activity that was co-precipitated with p53 in rat cells completely transformed by SV40 TAg. In FMH202 cells transformed by HBx, the in vitro kinase activity of p53 immune complexes was inhibited by the addition of 50 mM GTP (Mu$ ller et al., 1993) ; therefore, it is probable that the kinase co-precipitated with p53 in completely transformed FMH clone X5 is casein kinase II. The enhanced phosphorylation of p53 and the larger amount of coprecipitated cellular kinase is not due to an enhanced expression of p53 in HBx transformed FMH clones. p53 is immune precipitated in similar amounts from HBx transformed and XM transfected clones (Fig. 4 A) and stained equally well in Western blots (data not shown). Hence the half-life and quantity of p53 were not altered after transformation by HBx. p53 is present in wild-type conformation in HBx transformed and control clones because PAb240 (Fig. 4 A, B) did not precipitate p53, whereas PAb421 (Fig. 4 A, B) and PAb246 (data not shown) did precipitate p53.
The long latency of tumour growth in nude mice suggested that secondary events such as genomic rearrangements were necessary for tumour progression. Rearrangements and amplifications of the integrated HBV DNA fragments were indeed found in tumours from clones containing either the entire HBV genome (Ho$ hne et al., 1990) or HBx gene-containing clones X5 and X26 (Fig. 3) . Rearrangement of integrated HBV DNA was also found in FMH202 cells transfected and transformed with HBV DNA sequences (Luber et al., 1996) .
Two mechanisms for a presumed HBx mediated inactivation of p53 have been suggested. Direct physical interaction of HBx and p53 in vitro may lead to an impairment of p53 functions in vivo (Feitelson et al., 1993 ; Truant et al., 1995 ; Wang et al., 1994) ; or sequestration of p53 in the cytoplasm of HHD S. Schaefer and others S. Schaefer and others HCC developing HBx transgenic mice may lead to a functional inactivation of p53 (Ueda et al., 1995) . The present results do not support either of these hypotheses. The immune coprecipitation of HBx by p53 was inconclusive because HBx was not detected by Western blot or RIPA (data not shown). However, HBx and p53 did not co-localize by immune fluorescence (Fig. 6) .
Staining of the cytoplasm by immune fluorescence of the tumorigenic X5 and X26 clones under growth arrest conditions (Fig. 6 A, X5 , left panel) with MAbs PAb421, PAb240 and PAb246 was observed, while non-tumorigenic control clones showed normal nuclear staining of p53 (Fig. 6 A, XM1 , right panel). By immune precipitation of cytoplasmic and nuclear extracts from cells held under growth arrest conditions, p53 was found mainly in the nucleus of HBx transformed and control clones. Immune fluorescence with MAbs PAb242, PAb248 and 200.47 confirmed the finding of nuclear localization of p53 in HBx transformed clones X5 and X26. Interestingly, the latter three antibodies recognize epitopes in the amino terminus of p53 (aa 18-27, aa 43-53 and aa 78-87, respectively ; Lane et al., 1996) , whereas the MAbs that showed cytoplasmic staining recognize more carboxy-terminal epitopes (PAb421 : aa 363-372 ; PAb240 : a 207-212), or are known to be conformation dependent (PAb246, epitope mapped within aa 86-107 ; Lane et al., 1996 and references therein) . One explanation for the failure of PAb421, PAb240 and PAb246 to stain nuclear p53 might be that carboxyterminal epitopes are masked by p53-binding proteins such as casein kinase II under conditions of immune fluorescence. Casein kinase II is known to bind the carboxy terminus (aa 287-340) of p53 (Appel et al., 1995) . Cytoplasmic staining by PAb421 or PAb240 was either unspecific or detected the small amount of p53 that is physiologically present in the cytoplasm (Mosner et al., 1995) .
The present findings show that HBx is able to transform immortalized hepatocytes with low efficiency, but do not provide further evidence for the reported inactivation of p53 by HBx. Further studies on inactivation of p53 by HBx in FMH202 cells are not possible because of the transgene SV40 Tag used for generation of FMH202 cells, but the data suggest that HBx exerts its transforming capacity not only by inactivation of p53. Transformation by hepatitis B virus X protein Transformation by hepatitis B virus X protein 
